Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Heparin Market, by Type
1.4.2 North America Heparin Market, by Application
1.4.3 North America Heparin Market, by Route of Administration
1.4.4 North America Heparin Market, by End Use
1.4.5 North America Heparin Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Heparin Market by Type
3.1 North America Low Molecular Weight Heparin Market by Country
3.2 North America Unfractionated Heparin Market by Country
3.3 North America Ultra-low Molecular Weight Heparin Market by Country
Chapter 4. North America Heparin Market by Application
4.1 North America Atrial Fibrillation Market by Country
4.2 North America Coronary Artery Disease Market by Country
4.3 North America Venous Thromboembolism Market by Country
4.4 North America Renal Impairment Market by Country
4.5 North America Other Applications Market by Country
Chapter 5. North America Heparin Market by Route of Administration
5.1 North America Subcutaneous Market by Region
5.2 North America Intravenous Market by Region
Chapter 6. North America Heparin Market by End Use
6.1 North America Outpatient Market by Country
6.2 North America Inpatient Market by Country
Chapter 7. North America Heparin Market by Region
7.1 US Heparin Market
7.1.1 US Heparin Market by Type
7.1.2 US Heparin Market by Application
7.1.3 US Heparin Market by Route of Administration
7.1.4 US Heparin Market by End Use
7.2 Canada Heparin Market
7.2.1 Canada Heparin Market by Type
7.2.2 Canada Heparin Market by Application
7.2.3 Canada Heparin Market by Route of Administration
7.2.4 Canada Heparin Market by End Use
7.3 Mexico Heparin Market
7.3.1 Mexico Heparin Market by Type
7.3.2 Mexico Heparin Market by Application
7.3.3 Mexico Unfractionated Heparin Market by Route of Administration
7.3.4 Mexico Heparin Market by End Use
7.4 Rest of North America Heparin Market
7.4.1 Rest of North America Heparin Market by Type
7.4.2 Rest of North America Heparin Market by Application
7.4.3 Rest of North America Heparin Market by Route of Administration
7.4.4 Rest of North America Heparin Market by End Use
Chapter 8. Company Profiles
8.1 Baxter International, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expense
8.2 B. Braun Melsungen AG
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 Fresenius SE & Co. KGaA
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.1 Recent strategies and developments:
8.3.1.1 Partnerships, Collaborations, and Agreements:
8.3.1.2 Acquisition and Mergers:
8.3.1.3 Product Launches and Product Expansions:
8.4 Pfizer, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.5 Sanofi S.A.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.6 Teva Pharmaceutical Industries Ltd.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.7 Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
8.7.1 Company Overview
8.8 Dr. Reddy’s Laboratories Ltd.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 LEO Pharma A/S
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expense
8.10. Viatris, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expense
Unique Offerings 